Coordinating Pre-CAR T-Cell Care in DLBCL

In this segment, NP Stefanie Sigmund discusses strategies for maintaining continuity of care for patients with diffuse large B-cell lymphoma (DLBCL) awaiting evaluation or treatment at a CAR T-cell center. She highlights the role of email communication, nurse navigators, and triage nurses in coordinating care between community oncology practices and specialized treatment teams. NP Sigmund also describes common challenges patients face before treatment, including arranging transportation, securing lodging, identifying caregiver support, and managing anxiety about the treatment process. Dr. Caron A. Jacobson explains that community oncologists should not hesitate to refer patients because of advanced age, comorbidities, or concerns about managing the logistics of CAR T-cell therapy. She emphasizes that CAR T-cell centers have dedicated teams to support patient education, insurance authorization, scheduling, and lodging arrangements. The discussion reinforces the importance of timely referral and communication while clarifying that community practices do not need to manage every aspect of the treatment process themselves.